Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Bladder Cancer

Free Subscription 05.08.2019 1 Am J Clin Oncol 1 Anticancer Res 4 Arch Ital Urol Androl 1 Asian J Transfus Sci 1 Biosci Biotechnol Biochem 1 BMJ Open Gastroenterol 1 Cancer 1 Cancer Med 1 Cancer Sci 1 Cell Prolif 1 Cell Signal 1 Clin Sci (Lond) 1 Dis Markers 2 Eur Urol 1 FASEB J 2 Front Oncol 1 Indian J Pathol Microbiol 1 Int Braz J Urol 2 Int J Biol Sci 4 Int J Urol 1 Intern Med 1 J Am Osteopath Assoc 1 J Cancer Res Clin Oncol 1 J Carcinog 1 J Clin Pathol 1 J Minim Invasive Gynecol 4 J Urol 1 Medicine (Baltimore) 1 Mol Cancer 1 Nat Cell Biol 2 Oncol Rep 2 PLoS One 1 Prog Urol 1 Urol Oncol 1 Urologe A 2 World J Urol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Clin Oncol

1. D'RUMMO KA, TenNapel MJ, Shen X
   The Impact of Radiotherapy Facility Volume on the Survival and Guideline Concordance of Patients With Muscle-invasive Bladder Cancer Receiving Bladder-preservation Therapy.
   Am J Clin Oncol. 2019 Jul 25. doi: 10.1097/COC.0000000000000582.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

2. AKITAKE M, Yamaguchi A, Shiota M, Imada K, et al
   Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer.
   Anticancer Res. 2019;39:4325-4328.
   PubMed     Text format     Abstract available
   
   

   
   Arch Ital Urol Androl

3. ROMAGNOLI D, Mineo Bianchi F, Sadini P, Angiolini A, et al
   Pubis bone osteomyelitys after robotic radical cystectomy with continent intracorporeal urinary diversion: Multidisciplinary approach to a complex situation.
   Arch Ital Urol Androl. 2019;91:63-67.
   PubMed     Text format     Abstract available
   
   
4. MINEO BIANCHI F, Romagnoli D, D'Agostino D, Salvaggio A, et al
   Posterior muscle-fascial reconstruction and knotless urethro-neo bladder anastomosis during robot-assisted radical cystectomy: Description of the technique and its impact on urinary continence.
   Arch Ital Urol Androl. 2019;91:5-10.
   PubMed     Text format     Abstract available
   
   
5. DE ROSE AF, Balzarini F, Mantica G, Toncini C, et al
   Late urinary bladder metastasis from breast cancer.
   Arch Ital Urol Androl. 2019;91:60-62.
   PubMed     Text format     Abstract available
   
   
6. SODO M, Spirito L, La Rocca R, Bracale U, et al
   Partial cystectomy in young male for a urachal tumor masquerading a bladder leiomyoma.
   Arch Ital Urol Androl. 2019;91:51-52.
   PubMed     Text format     Abstract available
   
   

   
   Asian J Transfus Sci

7. JOSHI SR, Sheladiya A, Agrawal VN
   High thermal amplitude auto-anti-"N" complicating pretransfusion compatibility tests on a patient with malaria and bladder cancer.
   Asian J Transfus Sci. 2019;13:30-33.
   PubMed     Text format     Abstract available
   
   

   
   Biosci Biotechnol Biochem

8. LEE JW, Lee S, Ho JN, Youn JI, et al
   Antitumor effects of MutT homolog 1 inhibitors in human bladder cancer cells.
   Biosci Biotechnol Biochem. 2019 Jul 31:1-7. doi: 10.1080/09168451.2019.1648207.
   PubMed     Text format     Abstract available
   
   

   
   BMJ Open Gastroenterol

9. HABERSTROH W, Shafa S
   Pseudoachalasia secondary to metastatic bladder cancer.
   BMJ Open Gastroenterol. 2019;6:e000284.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

10. TAKAHASHI T
    Overall survival is the primary endpoint in a trial of neoadjuvant chemotherapy for bladder cancer?
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32415.
    PubMed     Text format    
    
    

    
    Cancer Med

11. BAE WK, Lee HJ, Park SH, Kim JH, et al
    Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analys
    Cancer Med. 2019 Jul 29. doi: 10.1002/cam4.2446.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Sci

12. HIROTSU Y, Yokoyama H, Amemiya K, Hagimoto T, et al
    Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancer.
    Cancer Sci. 2019 Aug 1. doi: 10.1111/cas.14155.
    PubMed     Text format     Abstract available
    
    

    
    Cell Prolif

13. LIU P, Li X, Guo X, Chen J, et al
    Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa-miR-132-3p/Sox5 signalling pathway.
    Cell Prolif. 2019;52:e12614.
    PubMed     Text format     Abstract available
    
    

    
    Cell Signal

14. LI X, He S, Tian Y, Weiss RM, et al
    Synergistic inhibition of GP130 and ERK signaling blocks chemoresistant bladder cancer cell growth.
    Cell Signal. 2019 Jul 30:109381. doi: 10.1016/j.cellsig.2019.109381.
    PubMed     Text format     Abstract available
    
    

    
    Clin Sci (Lond)

15. CHENG S, Wang G, Wang Y, Cai L, et al
    Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARgamma-mediated pathway in bladder cancer.
    Clin Sci (Lond). 2019 Jul 29. pii: CS20190587. doi: 10.1042/CS20190587.
    PubMed     Text format     Abstract available
    
    

    
    Dis Markers

16. TIAN DW, Wu ZL, Jiang LM, Gao J, et al
    KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo.
    Dis Markers. 2019;2019:4824902.
    PubMed     Text format     Abstract available
    
    

    
    Eur Urol

17. VOSKUILEN CS, van der Heijden MS, van Rhijn BWG
    Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Jul 24. pii: S0302-2838(19)30543.
    PubMed     Text format    
    
    
18. ELANDER NO, Hussain SA
    Mutation Analysis of the FGFR3-encoding gene Does Not Predict Response to Checkpoint Inhibitor Treatment in Metastatic Bladder Cancer.
    Eur Urol. 2019 Jul 26. pii: S0302-2838(19)30593.
    PubMed     Text format    
    
    

    
    FASEB J

19. YAN H, Ren S, Lin Q, Yu Y, et al
    Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.
    FASEB J. 2019 Aug 2:fj201900499RR. doi: 10.1096/fj.201900499.
    PubMed     Text format     Abstract available
    
    

    
    Front Oncol

20. ZHANG W, Mao S, Shi D, Zhang J, et al
    MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1.
    Front Oncol. 2019;9:619.
    PubMed     Text format     Abstract available
    
    
21. LI Y, Zhang H, Guo Y, Cai H, et al
    A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I-III Bladder Cancer Patients After Surgical Resection.
    Front Oncol. 2019;9:629.
    PubMed     Text format     Abstract available
    
    

    
    Indian J Pathol Microbiol

22. AGARWAL H, Babu S, Rana C, Kumar M, et al
    Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma.
    Indian J Pathol Microbiol. 2019;62:244-250.
    PubMed     Text format     Abstract available
    
    

    
    Int Braz J Urol

23. LI J, Yang F, He Q, Wang M, et al
    Laparoscopic radical cystectomy with intracorporeal ileal conduit: one center experience and clinical outcomes.
    Int Braz J Urol. 2019;45:560-571.
    PubMed     Text format     Abstract available
    
    

    
    Int J Biol Sci

24. LI A, Yao L, Fang Y, Yang K, et al
    Specifically blocking the fatty acid synthesis to inhibit the malignant phenotype of bladder cancer.
    Int J Biol Sci. 2019;15:1610-1617.
    PubMed     Text format     Abstract available
    
    
25. QI F, Tan B, Ma F, Zhu B, et al
    A Synthetic Light-switchable System based on CRISPR Cas13a Regulates the Expression of LncRNA MALAT1 and Affects the Malignant Phenotype of Bladder Cancer Cells.
    Int J Biol Sci. 2019;15:1630-1636.
    PubMed     Text format     Abstract available
    
    

    
    Int J Urol

26. YOSHIDA T, Kates M, Fujita K, Bivalacqua TJ, et al
    Predictive biomarkers for drug response in bladder cancer.
    Int J Urol. 2019 Aug 1. doi: 10.1111/iju.14082.
    PubMed     Text format     Abstract available
    
    
27. FUJIMURA T
    Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer.
    Int J Urol. 2019 Jul 30. doi: 10.1111/iju.14076.
    PubMed     Text format     Abstract available
    
    
28. TEISHIMA J, Matsubara A
    Editorial Comment to Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer.
    Int J Urol. 2019 Jul 30. doi: 10.1111/iju.14086.
    PubMed     Text format    
    
    
29. KOJIMA T
    Editorial Comment from Dr Kojima to Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, inductio
    Int J Urol. 2019 Jul 28. doi: 10.1111/iju.14074.
    PubMed     Text format    
    
    

    
    Intern Med

30. OKANO H, Asakawa H, Nose K, Tsuruga S, et al
    Hepatic Injury without Granulomatous Formation Associated with Intravesical Bacillus Calmette-Guerin Therapy.
    Intern Med. 2019;58:1429-1432.
    PubMed     Text format     Abstract available
    
    

    
    J Am Osteopath Assoc

31. MARTINGANO D, Ramirez LC, Bjurlin MA
    Osteopathic Evaluation of Urinary Retention Caused by Atypical Presentation of Invasive Cervical Cancer Mimicking Primary Urothelial Tumor.
    J Am Osteopath Assoc. 2018;118:685-688.
    PubMed     Text format     Abstract available
    
    

    
    J Cancer Res Clin Oncol

32. KITAGAWA K, Shigemura K, Sung SY, Chen KC, et al
    Possible correlation of sonic hedgehog signaling with epithelial-mesenchymal transition in muscle-invasive bladder cancer progression.
    J Cancer Res Clin Oncol. 2019 Jul 31. pii: 10.1007/s00432-019-02987.
    PubMed     Text format     Abstract available
    
    

    
    J Carcinog

33. SAMISHINA EA, Blinova EV, Roshchin DA, Suslova IR, et al
    Programmed death-ligand 1 signaling pathway involves in bladder cancer growth and progression.
    J Carcinog. 2019;18:3.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Pathol

34. MAGERS MJ, Kaimakliotis HZ, Barboza MP, Bandali E, et al
    Clinicopathological characteristics of ypT0N0 urothelial carcinoma following neoadjuvant chemotherapy and cystectomy.
    J Clin Pathol. 2019;72:550-553.
    PubMed     Text format     Abstract available
    
    

    
    J Minim Invasive Gynecol

35. SCHWARTZ E, Faller E, Akladios CY, Greget M, et al
    Total Laparoscopic Hysterectomy for Endometriosis and an Arteriovenous Malformation.
    J Minim Invasive Gynecol. 2019;26:363-364.
    PubMed     Text format     Abstract available
    
    

    
    J Urol

36. CHANG SS
    Re: Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis.
    J Urol. 2019 Jul 31:10109701JU00005794608369953.
    PubMed     Text format    
    
    
37. BJURLIN MA, Nielsen ME
    Editorial Comment.
    J Urol. 2019;202:246.
    PubMed     Text format    
    
    
38. CHANG SS
    Re: Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model.
    J Urol. 2019 Jul 31:101097JU0000000000000479. doi: 10.1097/JU.0000000000000479.
    PubMed     Text format    
    
    
39. CHANG SS
    Re: Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.
    J Urol. 2019 Jul 31:10109701JU00005794560657170.
    PubMed     Text format    
    
    

    
    Medicine (Baltimore)

40. CALO B, Sanguedolce F, Fortunato F, Stallone G, et al
    The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer.
    Medicine (Baltimore). 2019;98:e16223.
    PubMed     Text format     Abstract available
    
    

    
    Mol Cancer

41. FENG J, Chen K, Dong X, Xu X, et al
    Genome-wide identification of cancer-specific alternative splicing in circRNA.
    Mol Cancer. 2019;18:35.
    PubMed     Text format     Abstract available
    
    

    
    Nat Cell Biol

42. CHEN X, Li A, Sun BF, Yang Y, et al
    5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs.
    Nat Cell Biol. 2019;21:978-990.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

43. WANG F, Li Y, Shan F, Zhang Q, et al
    Upregulation of JMJD2A promotes migration and invasion in bladder cancer through regulation of SLUG.
    Oncol Rep. 2019 Jul 23. doi: 10.3892/or.2019.7246.
    PubMed     Text format     Abstract available
    
    
44. TOLLE A, Buckendahl L, Jung K
    Plasma miR15b5p and miR5905p for distinguishing patients with bladder cancer from healthy individuals.
    Oncol Rep. 2019 Jul 24. doi: 10.3892/or.2019.7247.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

45. JIANG WD, Yuan PC
    Molecular network-based identification of competing endogenous RNAs in bladder cancer.
    PLoS One. 2019;14:e0220118.
    PubMed     Text format     Abstract available
    
    
46. KAWAHARA T, Kojima T, Kandori S, Kurobe M, et al
    TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer.
    PLoS One. 2019;14:e0220173.
    PubMed     Text format     Abstract available
    
    

    
    Prog Urol

47. BABOUDJIAN M, Lechevallier E, Michel F, Ben Othman K, et al
    [Does diagnostic ureterorenoscopy increase the risk of bladder recurrence after total nephroureterectomy? A review of the literature].
    Prog Urol. 2019;29:138-146.
    PubMed     Text format     Abstract available
    
    

    
    Urol Oncol

48. GENITSCH V, Kollar A, Vandekerkhove G, Blarer J, et al
    Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Urol Oncol. 2019 Jul 26. pii: S1078-1439(19)30250.
    PubMed     Text format     Abstract available
    
    

    
    Urologe A

49. HUPE MC, Gakis G, Seiler R
    [Molecular tumor board-urothelial cancer].
    Urologe A. 2019;58:760-767.
    PubMed     Text format     Abstract available
    
    

    
    World J Urol

50. BLACK PC
    Hope, hype and biology: the current biomarker landscape in bladder cancer.
    World J Urol. 2019 Jul 27. pii: 10.1007/s00345-019-02885.
    PubMed     Text format    
    
    
51. REIS LO
    Non-muscle invasive bladder cancer (NMIBC): boiling arena and promissory future.
    World J Urol. 2019 Aug 1. pii: 10.1007/s00345-019-02894.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: